Trials / Completed
CompletedNCT04097106
Synbiotic Dietary Supplement and Gut Microbiota
Synbiotic Supplement Effects on Gastrointestinal Symptoms and Gut Microbiota and Fecal Metabolomics
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- The Cleveland Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To test the feasibility and safety of our designer synbiotic on gastrointestinal symptoms and gut microbiota and fecal metabolomics.
Detailed description
This will be a double-blinded, randomized, placebo-controlled paired crossover pilot study in healthy controls aimed to evaluate gastrointestinal tolerance of a synbiotic dietary supplement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Synbiotic | Synbiotic dietary supplement in capsule form |
Timeline
- Start date
- 2020-11-10
- Primary completion
- 2022-06-27
- Completion
- 2022-06-27
- First posted
- 2019-09-20
- Last updated
- 2024-12-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04097106. Inclusion in this directory is not an endorsement.